Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes-Reference-Cited by-同舟云学术

Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes

Published:2023-05-01 Issue:11 Volume:107 Page:3495-3508
ISSN:0175-7598
Container-title:Applied Microbiology and Biotechnology
language:en
Short-container-title:Appl Microbiol Biotechnol

Author:

Garay Ernesto,Fontana Diego^ORCID,Villarraza Javier,Fuselli Antonela,Gugliotta Agustina,Antuña Sebastián,Tardivo Belén,Rodríguez María Celeste,Gastaldi Victoria,Battagliotti Juan Manuel,Alvarez Diego,Castro Eliana,Cassataro Juliana,Ceaglio Natalia,Prieto Claudio

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,General Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s00253-023-12545-w.pdf

Reference63 articles.

1. Arista-Romero M, Delcanale P, Pujals S, Albertazzi L (2021) Nanoscale mapping of recombinant viral proteins: from cells to virus-like particles. ACS Photonics 9:101–109. https://doi.org/10.1021/acsphotonics.1c01154

2. Aston-Deaville S, Carlsson E, Saleem M, Thistlethwaite A, Chan H, Maharjan S, Facchetti A, Feavers IM, Alistair Siebert C, Collins RF, Roseman A, Derrick JP (2020) An assessment of the use of hepatitis B virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis. Vaccine 38:3201–3209. https://doi.org/10.1016/j.vaccine.2020.03.001

3. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403–416. https://doi.org/10.1056/NEJMOA2035389/SUPPL_FILE/NEJMOA2035389_DATA-SHARING.PDF

4. Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RD (2021) Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 398:2093–2100. https://doi.org/10.1016/S0140-6736(21)02249-2

5. Battagliotti JM, Fontana D, Etcheverrigaray M, Kratje R, Prieto C (2020) Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein. Antiviral Res 183:104936. https://doi.org/10.1016/j.antiviral.2020.104936

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?;Health Sciences Review;2023-12